X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3618) 3618
Publication (413) 413
Book Review (77) 77
Book / eBook (70) 70
Book Chapter (5) 5
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3030) 3030
index medicus (2211) 2211
female (1902) 1902
male (1766) 1766
adult (1662) 1662
oncology (1323) 1323
middle aged (1303) 1303
hematology (1145) 1145
adolescent (937) 937
treatment outcome (932) 932
psychiatry (927) 927
schizophrenia (737) 737
1st complete remission (735) 735
aged (728) 728
chemotherapy (727) 727
transplantation (620) 620
young adult (605) 605
antineoplastic combined chemotherapy protocols - therapeutic use (563) 563
prognosis (561) 561
remission induction (517) 517
1st remission (507) 507
1st-line treatment (484) 484
bone-marrow-transplantation (459) 459
acute myelogenous leukemia (457) 457
follow-up studies (449) 449
cancer (445) 445
acute myeloid-leukemia (436) 436
recurrence (433) 433
care and treatment (422) 422
risk factors (414) 414
child (406) 406
immunology (405) 405
disease-free survival (402) 402
retrospective studies (399) 399
research (383) 383
transplantation, homologous (383) 383
remission (368) 368
stem-cell transplantation (363) 363
follow-up (360) 360
leukemia, myeloid, acute - therapy (342) 342
psychosis (320) 320
hematopoietic stem cell transplantation (319) 319
therapy (319) 319
survival analysis (316) 316
analysis (298) 298
1st-episode schizophrenia (292) 292
1st-episode psychosis (286) 286
child, preschool (282) 282
health aspects (278) 278
stem cells (276) 276
combined modality therapy (275) 275
time factors (267) 267
relapse (266) 266
patients (265) 265
leukemia (253) 253
transplantation, autologous (250) 250
acute myeloid leukemia (249) 249
antipsychotic agents - therapeutic use (247) 247
trial (246) 246
hematopoietic stem cells (241) 241
schizophrenic psychology (241) 241
survival rate (241) 241
antineoplastic agents - therapeutic use (233) 233
acute lymphoblastic-leukemia (229) 229
survival (229) 229
bone marrow transplantation (225) 225
hematopoietic stem cell transplantation - methods (224) 224
1st episode (223) 223
drug therapy (220) 220
pharmacology & pharmacy (219) 219
prospective studies (219) 219
schizophrenia - drug therapy (218) 218
precursor cell lymphoblastic leukemia-lymphoma - therapy (217) 217
transplantation conditioning - methods (212) 212
leukemia, myeloid, acute - mortality (211) 211
mental disorders (205) 205
infant (204) 204
acute disease (203) 203
clinical neurology (202) 202
total-body irradiation (202) 202
diagnosis (197) 197
minimal residual disease (196) 196
children (195) 195
article (194) 194
aged, 80 and over (193) 193
antineoplastic combined chemotherapy protocols - adverse effects (191) 191
psychiatric status rating scales (188) 188
hematology, oncology and palliative medicine (186) 186
versus-host-disease (183) 183
patient outcomes (180) 180
neurosciences (179) 179
leukemia, myeloid, acute - drug therapy (177) 177
open-label (174) 174
1st-line therapy (172) 172
schizophrenia - diagnosis (172) 172
studies (172) 172
risk (171) 171
clinical trials (168) 168
psychotic disorders - psychology (168) 168
double-blind (167) 167
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (38) 38
UTL at Downsview - May be requested (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Knox College (Caven) - Stacks (5) 5
Online Resources - Online (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
Trinity College (John W Graham) - Stacks (5) 5
UofT at Mississauga - Stacks (5) 5
St. Michael's College (John M. Kelly) - 3rd Floor (4) 4
Pontifical Inst. Mediaeval Studies - Library use only (3) 3
Regis College - Stacks (3) 3
St. Augustine's Seminary - Stacks (3) 3
Trinity College (John W Graham) - Storage (3) 3
UofT at Scarborough - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Victoria University Emmanuel College - Stacks (2) 2
East Asian (Cheng Yu Tung) - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Knox College (Caven) - Reference (1) 1
Law (Bora Laskin) - Stacks (1) 1
Regis College - Reference (1) 1
St. Augustine's Seminary - Reference (1) 1
Trinity College (John W Graham) - Reference (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University Emmanuel College - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3626) 3626
French (22) 22
German (18) 18
Spanish (8) 8
Russian (7) 7
Polish (6) 6
Italian (4) 4
Latin (4) 4
Turkish (4) 4
Korean (2) 2
Hebrew (1) 1
Irish (1) 1
Japanese (1) 1
Middle (1) 1
Old French (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 12/2014, Volume 137, Issue 12, pp. 3213 - 3222
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 2035 - 2042
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) offers curative potential to a number of older patients with acute myeloid leukemia (AML) in... 
Center for International Blood and Marrow Transplant Research (CIBMTR) | acute myeloid leukemia (AML) | second complete remission | allogeneic transplant | elderly | AML | ADULT PATIENTS | DIAGNOSIS | PROGNOSTIC-FACTORS | 1ST COMPLETE REMISSION | ONCOLOGY | MYELODYSPLASTIC-SYNDROME | DONOR TRANSPLANTATION | STEM-CELL TRANSPLANTATION | PREDICT SURVIVAL | AGE | Multivariate Analysis | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Neoplasm Recurrence, Local - therapy | Hematopoietic Stem Cell Transplantation | Male | Survival Rate | Methotrexate - therapeutic use | Remission Induction | Transplantation, Homologous | Disease-Free Survival | Mycophenolic Acid - therapeutic use | Calcineurin Inhibitors - therapeutic use | Female | Graft vs Host Disease - prevention & control | Neoplasm Recurrence, Local - genetics | Aged | Retrospective Studies | Transplantation Conditioning | Leukemia, Myeloid, Acute - therapy | Cohort Studies | Leukemia, Myeloid, Acute - genetics | Bone marrow | Aged patients | Usage | Transplantation | Health aspects | Transplants & implants | Myeloid leukemia | Leukemia | Health risks | Multivariate analysis | Risk analysis | Patients | Survival | Blood | Risk factors | Hemopoiesis | Incidence | Confidence intervals | Cytogenetics | Remission | Acute myeloid leukemia | Age | Cancer | Geriatrics | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3073 - 3079
BACKGROUND High‐dose chemotherapy and autologous stem cell transplantation (HDC‐ASCT) is a therapeutic option for patients with primary central nervous system... 
busulfan | high‐dose chemotherapy | primary central nervous system lymphoma (PCNSL) | autologous stem cell transplantation (ASCT) | cyclophosphamide | thiotepa | high-dose chemotherapy | PRIMARY CNS LYMPHOMA | 1ST-LINE TREATMENT | INTENSIVE CHEMOTHERAPY | IMMUNOCHEMOTHERAPY | CHEMOIMMUNOTHERAPY | METHOTREXATE | PHASE-II | WHOLE-BRAIN RADIOTHERAPY | CYTARABINE | THERAPY | ONCOLOGY | Cyclophosphamide - administration & dosage | Follow-Up Studies | Thiotepa - administration & dosage | Bacterial Infections - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Busulfan - administration & dosage | Lymphoma - therapy | Dacarbazine - analogs & derivatives | Adult | Female | Retrospective Studies | Dacarbazine - administration & dosage | Kaplan-Meier Estimate | Central Nervous System Neoplasms - therapy | Remission Induction | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Stem Cell Transplantation - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucositis - etiology | Methotrexate - administration & dosage | Aged | Temozolomide | Transplantation Conditioning | Stem Cell Transplantation - adverse effects | Chemotherapy | Usage | Care and treatment | Nervous system cancer | Thiotepa | Stem cells | Dosage and administration | Transplantation | Busulfan | Radiotherapy | Cancer | Brain | Toxicity | Central nervous system | Stem cell transplantation | Nervous system | Institutions | Confidence intervals | Cytarabine | Consolidation | Remission | Bacteria | Diagnosis | Conditioning | Methotrexate | Age | Autografts | Mucositis | Rituximab | Radiation therapy | Patients | Survival | Disease control | Lymphoma | Amplification | Cyclophosphamide | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 02/2017, Volume 23, Issue 2, pp. 278 - 284
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2013, Volume 88, Issue 8, pp. 634 - 641
The role of reduced‐intensity conditioning (RIC) in adult acute lymphoblastic leukemia (ALL) remains unclear because of the small sample size, short follow‐up... 
HYPER-CVAD | INDUCTION THERAPY | ACUTE LYMPHOCYTIC-LEUKEMIA | SIBLING DONOR